Vir Biotechnology PE ratio VIR

Share price divided by earnings per share over the last twelve months, since 2022.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 6.4×; May 2023
Peer median: 29.2×

Vir Biotechnology has no meaningful PE ratio today: it lost $1.86 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in May 2023, at 6.4×.

PE ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2023	6.4×	2.7×	6.8×
2022	3.0×	2.3×	6.7×

Against its peers

Companies in Biotechnology nearest Vir Biotechnology's size, closest first, today.

Company	PE ratio
VIRVir Biotechnology	n/m
VCELVericel	92.5×
ADMAAdma Biologics	15.3×
MGTXMeiraGTx	13.0×
KRYSKrystal Biotech	39.0×
RGENRepligen	242×
TECHBIO-TECHNE	63.1×
HALOHalozyme Therapeutics	37.5×
NBIXNeurocrine Biosciences	20.9×
PLXProtalix BioTherapeutics	11.1×
EXELExelixis	20.3×
Peer median	29.2×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Vir Biotechnology

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.